Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Neutralizing Antibodies
1.2.3 Anti-inflammatory Drugs
1.3 Market by Application
1.3.1 Global Biologic Medication in COVID-19 Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medication in COVID-19 Market Perspective (2018-2034)
2.2 Biologic Medication in COVID-19 Growth Trends by Region
2.2.1 Global Biologic Medication in COVID-19 Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Biologic Medication in COVID-19 Historic Market Size by Region (2018-2023)
2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Region (2024-2034)
2.3 Biologic Medication in COVID-19 Market Dynamics
2.3.1 Biologic Medication in COVID-19 Industry Trends
2.3.2 Biologic Medication in COVID-19 Market Drivers
2.3.3 Biologic Medication in COVID-19 Market Challenges
2.3.4 Biologic Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Medication in COVID-19 Players by Revenue
3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2018-2023)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2018-2023)
3.2 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
3.4 Global Biologic Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2024
3.5 Biologic Medication in COVID-19 Key Players Head office and Area Served
3.6 Key Players Biologic Medication in COVID-19 Product Solution and Service
3.7 Date of Enter into Biologic Medication in COVID-19 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medication in COVID-19 Breakdown Data by Type
4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2018-2023)
4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2024-2034)
5 Biologic Medication in COVID-19 Breakdown Data by Application
5.1 Global Biologic Medication in COVID-19 Historic Market Size by Application (2018-2023)
5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Biologic Medication in COVID-19 Market Size (2018-2034)
6.2 North America Biologic Medication in COVID-19 Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Biologic Medication in COVID-19 Market Size by Country (2018-2023)
6.4 North America Biologic Medication in COVID-19 Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic Medication in COVID-19 Market Size (2018-2034)
7.2 Europe Biologic Medication in COVID-19 Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Biologic Medication in COVID-19 Market Size by Country (2018-2023)
7.4 Europe Biologic Medication in COVID-19 Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic Medication in COVID-19 Market Size (2018-2034)
8.2 Asia-Pacific Biologic Medication in COVID-19 Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic Medication in COVID-19 Market Size (2018-2034)
9.2 Latin America Biologic Medication in COVID-19 Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Biologic Medication in COVID-19 Market Size by Country (2018-2023)
9.4 Latin America Biologic Medication in COVID-19 Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Medication in COVID-19 Market Size (2018-2034)
10.2 Middle East & Africa Biologic Medication in COVID-19 Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medication in COVID-19 Introduction
11.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Biologic Medication in COVID-19 Introduction
11.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Biologic Medication in COVID-19 Introduction
11.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Medication in COVID-19 Introduction
11.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Biologic Medication in COVID-19 Introduction
11.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Shutaishen
11.6.1 Shutaishen Company Detail
11.6.2 Shutaishen Business Overview
11.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
11.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.6.5 Shutaishen Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Biologic Medication in COVID-19 Introduction
11.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.7.5 Biogen Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Detail
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Vir Biotech
11.9.1 Vir Biotech Company Detail
11.9.2 Vir Biotech Business Overview
11.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
11.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.9.5 Vir Biotech Recent Development
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Detail
11.10.2 Junshi Biosciences Business Overview
11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
11.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.10.5 Junshi Biosciences Recent Development
11.11 Anke Biotechnology
11.11.1 Anke Biotechnology Company Detail
11.11.2 Anke Biotechnology Business Overview
11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
11.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.11.5 Anke Biotechnology Recent Development
11.12 OncoImmune
11.12.1 OncoImmune Company Detail
11.12.2 OncoImmune Business Overview
11.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
11.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2018-2023)
11.12.5 OncoImmune Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Neutralizing Antibodies
Table 3. Key Players of Anti-inflammatory Drugs
Table 4. Global Biologic Medication in COVID-19 Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Biologic Medication in COVID-19 Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Biologic Medication in COVID-19 Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Biologic Medication in COVID-19 Market Share by Region (2018-2023)
Table 8. Global Biologic Medication in COVID-19 Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Biologic Medication in COVID-19 Market Share by Region (2024-2034)
Table 10. Biologic Medication in COVID-19 Market Trends
Table 11. Biologic Medication in COVID-19 Market Drivers
Table 12. Biologic Medication in COVID-19 Market Challenges
Table 13. Biologic Medication in COVID-19 Market Restraints
Table 14. Global Biologic Medication in COVID-19 Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Biologic Medication in COVID-19 Market Share by Players (2018-2023)
Table 16. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2024)
Table 17. Ranking of Global Top Biologic Medication in COVID-19 Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Biologic Medication in COVID-19 Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biologic Medication in COVID-19 Product Solution and Service
Table 21. Date of Enter into Biologic Medication in COVID-19 Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biologic Medication in COVID-19 Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2018-2023)
Table 25. Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2024-2034)
Table 27. Global Biologic Medication in COVID-19 Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2018-2023)
Table 29. Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2024-2034)
Table 31. North America Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Biologic Medication in COVID-19 Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Biologic Medication in COVID-19 Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Biologic Medication in COVID-19 Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Biologic Medication in COVID-19 Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Biologic Medication in COVID-19 Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Biologic Medication in COVID-19 Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Biologic Medication in COVID-19 Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Biologic Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2024-2034) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Biologic Medication in COVID-19 Product
Table 49. Roche Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Biologic Medication in COVID-19 Product
Table 54. Sanofi Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Biologic Medication in COVID-19 Product
Table 59. Novartis Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Biologic Medication in COVID-19 Product
Table 64. Merck Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Bayer Company Detail
Table 67. Bayer Business Overview
Table 68. Bayer Biologic Medication in COVID-19 Product
Table 69. Bayer Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Shutaishen Company Detail
Table 72. Shutaishen Business Overview
Table 73. Shutaishen Biologic Medication in COVID-19 Product
Table 74. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 75. Shutaishen Recent Development
Table 76. Biogen Company Detail
Table 77. Biogen Business Overview
Table 78. Biogen Biologic Medication in COVID-19 Product
Table 79. Biogen Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. Regeneron Pharmaceuticals Company Detail
Table 82. Regeneron Pharmaceuticals Business Overview
Table 83. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product
Table 84. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 85. Regeneron Pharmaceuticals Recent Development
Table 86. Vir Biotech Company Detail
Table 87. Vir Biotech Business Overview
Table 88. Vir Biotech Biologic Medication in COVID-19 Product
Table 89. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 90. Vir Biotech Recent Development
Table 91. Junshi Biosciences Company Detail
Table 92. Junshi Biosciences Business Overview
Table 93. Junshi Biosciences Biologic Medication in COVID-19 Product
Table 94. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 95. Junshi Biosciences Recent Development
Table 96. Anke Biotechnology Company Detail
Table 97. Anke Biotechnology Business Overview
Table 98. Anke Biotechnology Biologic Medication in COVID-19 Product
Table 99. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 100. Anke Biotechnology Recent Development
Table 101. OncoImmune Company Detail
Table 102. OncoImmune Business Overview
Table 103. OncoImmune Biologic Medication in COVID-19 Product
Table 104. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2018-2023) & (US$ Million)
Table 105. OncoImmune Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Medication in COVID-19 Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Biologic Medication in COVID-19 Market Share by Type: 2024 VS 2034
Figure 3. Neutralizing Antibodies Features
Figure 4. Anti-inflammatory Drugs Features
Figure 5. Global Biologic Medication in COVID-19 Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 6. Global Biologic Medication in COVID-19 Market Share by Application: 2024 VS 2034
Figure 7. COVID-19 Case Studies
Figure 8. Influenza Case Studies
Figure 9. Malaria Case Studies
Figure 10. Others Case Studies
Figure 11. Biologic Medication in COVID-19 Report Years Considered
Figure 12. Global Biologic Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Biologic Medication in COVID-19 Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Biologic Medication in COVID-19 Market Share by Region: 2024 VS 2034
Figure 15. Global Biologic Medication in COVID-19 Market Share by Players in 2024
Figure 16. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2024
Figure 18. North America Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Biologic Medication in COVID-19 Market Share by Country (2018-2034)
Figure 20. United States Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Biologic Medication in COVID-19 Market Share by Country (2018-2034)
Figure 24. Germany Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Biologic Medication in COVID-19 Market Share by Region (2018-2034)
Figure 32. China Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Biologic Medication in COVID-19 Market Share by Country (2018-2034)
Figure 40. Mexico Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Biologic Medication in COVID-19 Market Share by Country (2018-2034)
Figure 44. Turkey Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Biologic Medication in COVID-19 Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 50. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 51. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 52. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 54. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 55. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 56. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 57. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed